Study title: A randomized open study to investigate the boosting effect of VAQTA and AVAXIM following a single dose of AVAXIM (PM-MSD U98-XQ-003)
Type of medicine: Non-centrally authorised vaccines | |||||
Therapeutic area: Virus Diseases [C02] | |||||
Brands: Please see report, Please see report, Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: Inactivated hepatitis A virus | |||||
ATC code: J07BC02 | |||||
Document link: | |||||
Document date: | |||||
Study number: P061 - "Immunizing children to protect against the increasing risk of hepatitis A in adolescents and young adults in South Korea." Sohn, Y.M., et al., Southeast Asian J. Trop. Med. Public Health 3... | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |